UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event
reported): November
2, 2020
|
SOLLENSYS CORP.
|
|
(Exact
name of registrant as specified in its charter)
|
|
Nevada
|
|
333-174581
|
|
80-0651816
|
|
(State
or other jurisdiction
of
incorporation or organization)
|
|
(Commission
File
Number)
|
|
(IRS
Employer
Identification
No.)
|
2475 Palm Bay Rd NE, Suite 120
Palm Bay, FL 32905
(Address of principal executive offices)
(866) 438-7657
(Registrant’s telephone number, including area
code)
N/A
(Former name or former address, if changed since last
report)
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions (see General Instruction A.2.
below):
|
[
] Written communications pursuant to Rule 425 under the
Securities Act (17 CFR 230.425)
|
|
|
|
|
|
[
] Soliciting material pursuant to Rule 14a-12 under the
Exchange Act (17 CFR 240.14a -12)
|
|
|
|
|
|
[
] Pre-commencement communications pursuant to Rule 14d-2(b)
under the Exchange Act (17 CFR 240.14d -2(b))
|
|
|
|
|
|
[
] Pre-commencement communications pursuant to Rule 13e-4(c)
under the Exchange Act (17 CFR 240.13e -4(c))
|
|
Securities registered pursuant to Section 12(b) of the
Act:
|
Title of each class
|
|
Trading Symbol(s)
|
|
Name of each exchange on which registered
|
|
N/A
|
|
N/A
|
|
N/A
|
Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933
(§230.405 of this chapter) or Rule 12b-2 of the Securities
Exchange Act of 1934 (§240.12b-2 of this
chapter).
Emerging growth company [ ]
If an emerging growth company, indicate by check mark if the
registrant has elected not to use the extended transition period
for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act. [
]
Item 8.01. Other Events.
The previously disclosed 1-for-120 reverse stock split (the
“Reverse Split”) of the issued and outstanding common
stock, par value $0.001 per share, of Sollensys Corp. (the
“Company”) became effective on November 2, 2020.
Accordingly, effective November 2, 2020, every 120 shares of the
Company’s issued and outstanding common stock will be
converted into one share of common stock, without any change in the
par value per share. No fractional shares of common stock will be
issued in connection with the Reverse Split. If, as a result of the
Reverse Split, a shareholder would otherwise hold a fractional
share, the shareholder will receive, in lieu of the issuance of
such fractional share, one whole share of common
stock.
In connection with the Reverse Split, immediately after the Reverse
Split became effective on November 2, 2020, the Company also
effected a decrease in the number of authorized shares of Company
common stock from 12,000,000,000 shares to 300,000,000 shares
following the Reverse Split, with no change in the par value
thereof.
After giving effect to the Reverse Split, Eagle Lake Laboratories,
Inc., the Company’s majority shareholder, continues to hold
95.8% of the Company’s issued and outstanding shares of
common stock.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of
1934, the registrant has duly caused this amended report to be
signed on its behalf by the undersigned hereunto duly
authorized.
|
|
SOLLENSYS CORP.
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
Dated:
November 2, 2020
|
By:
|
/s/ Donald Beavers
|
|
|
|
|
|
Donald
Beavers
Chief
Executive Officer
|
|
|